FEDERICO
MARTINON TORRES
Profesor titular de universidade
Publicacións (519) Publicacións de FEDERICO MARTINON TORRES
2024
-
4CMenB journey to the 10-year anniversary and beyond
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants
Journal of Infectious Diseases, Vol. 229, pp. S112-S119
-
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
Journal of Infectious Diseases, Vol. 229, pp. S100-S111
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study
Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8
-
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
-
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 78, Núm. 6, pp. 1732-1744
-
Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))
Archivos de Bronconeumologia
-
External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care
The Journal of infectious diseases, Vol. 229, Núm. 1, pp. S18-S24
-
External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children
Archives of Disease in Childhood, Vol. 109, Núm. 1, pp. 58-66
-
GUANIN: an all-in-one GUi-driven analyzer for NanoString interactive normalization
Bioinformatics, Vol. 40, Núm. 8
-
Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus Hospitalization in Young Children <5 Years of age
Journal of Infectious Diseases, Vol. 230, Núm. 2, pp. e333-e341
-
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
The Journal of experimental medicine, Vol. 221, Núm. 2
-
Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study
The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338
-
How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?
Influenza and other Respiratory Viruses, Vol. 18, Núm. 6
-
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023
Nature Medicine, Vol. 30, Núm. 6, pp. 1559-1563
-
Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease
Journal of Translational Medicine, Vol. 22, Núm. 1